28 January 2019: Promotion of Propecia (finasteride) by 皇冠体育app Belgravia Centre
Updated 14 May 2019
漏 Crown copyright 2019
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, 皇冠体育app National Archives, Kew, London TW9 4DU, or email: [email protected].
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at /government/publications/advertising-investigations-january-2019/28-january-2019-promotion-of-propecia-finasteride-by-the-belgravia-centre
皇冠体育app MHRA became aware of a webpage entitled 鈥淟ong term safety of Propecia鈥� published on 皇冠体育app Belgravia Centre website. We were concerned that some of the information presented was not consistent with the Summary of Product Characteristics (SPC) for Propecia.
皇冠体育app Belgravia Centre confirmed that the page had been removed as it related to a service that they no longer offered. 皇冠体育appy also carried out a review of all material relating to finasteride to ensure consistency with the relevant SPCs.